Lazard Research & Insights
January 05, 2026
Annual Review of Shareholder Activism 2025
Lazard’s 2025 Review of Shareholder Activism highlights key trends and data in shareholder activism activity throughout the year.
Lazard Global Biopharmaceutical Leaders Study 2025
Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.
The Geopolitics of Biotech
A new report, The Geopolitics of Biotech, from Lazard’s Geopolitical Advisory team examines critical business, policy, and regulatory forces reshaping the global biotechnology sector today.
